Actions of R- and S-verapamil and nifedipine on rat vascular and intestinal smooth muscle

Autonomic and Autacoid Pharmacology

Volumn 24, Issue 3, 2004, Pages 63-67

  Cleary, L ^a   Vandeputte, C ^a   Kelly, J G ^a   Docherty, J R ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Irritable bowel syndrome; Nifedipine; R verapamil; Rat colon; S verapamil

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; POTASSIUM CHLORIDE; VERAPAMIL;

ANIMAL TISSUE; AORTA; ARTICLE; COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; ELECTROSTIMULATION; EPIDIDYMIS; INTESTINE MUSCLE; IRRITABLE COLON; MALE; NERVE POTENTIAL; NONHUMAN; PROSTATE; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; VAS DEFERENS; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; CALCIUM CHANNEL BLOCKERS; COLON; ELECTRIC STIMULATION; MALE; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; STEREOISOMERISM; VAS DEFERENS; VERAPAMIL;

EID: 8844266045     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2004.00317.x     Document Type: Article

References (22)

1. AWAD, R., DIBILDOX, M. & ORTIZ, F. (1995). Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial. Acta Gastroenterol. Latinoam., 25, 137-144.
2. BROWN, D.A., DOCHERTY, J.R., FRENCH, A.M., MACDONALD, A., MCGRATH, J.C. & SCOTT, N.C. (1983). Separation of noradrenergic and non-noradrenergic contractions to field stimulation in the rat vas deferens. Br. J. Pharmacol., 79, 379-393.
3. CHIU, A.T., MCCALL, D.E., THOOLEN, M.J. & TIMMERMANS, P.B. (1986). Ca++ utilization in the constriction of rat aorta to full and partial alpha-1 adrenoceptor agonists. J. Pharmacol. Exp. Ther., 238, 224-231.
4. DOCHERTY, J.R., CLEARY, L., VANDEPUTTE, C. & KELLY, J.G. (2003). Actions of R- and S-verapamil and nifedipine on rat vascular and intestinal smooth muscle. Autonom. Neurosci. Basic Clin., 106, 44.
5. ENDERS, G. (1997). Clinical approaches to male infertility with a case report of possible nifedipine-induced sperm dysfunction. J. Am. Board Fam. Pract., 10, 131-136.
6. FLETCHER, A. & BULPITT, C. (1992). Quality of life in the treatment of hypertension. The effect of calcium antagonists. Drugs, 44 (Suppl. 1), 135-140.
7. GOETZ, A.S., KING, H.K., WARD, S.D.C., TRUE, T.A., RIMELE, T.J. & SAUSSY, D.L. (1995). BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors. Eur. J. Pharmacol., 272, R5-R6.
8. GUNN, M.C., CAVIN, A.A. & MANSFIELD, J.C. (2003). Management of irritable bowel syndrome. Postgrad. Med. J., 79, 154-158.
9. HEDNER, T. (1986). Calcium channel blockers: spectrum of side effects and drug interactions. Acta Pharmacol. Toxicol., 58 (Suppl. 2), 119-130.
10. 1-adrenoreceptor mediating contractions of rat vas deferens. Br. J. Pharmacol., 128, 1323-1331.
11. KARLINER, J.S., MOTULSKY, H.J., DUNLAP, J., BROWN, J.H. & INSEL, P.A. (1982). Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium. J. Cardiovasc. Pharmacol., 4, 515-520.
12. KRONER, B.A., MULLIGAN, T. & BRIGGS, G.C. (1993). Effect of frequently prescribed cardiovascular medications on sexual function: a pilot study. Ann. Pharmacother., 27, 1329-1332.
13. LU, C.L., CHEN, C.Y., CHANG, F.Y., CHANG, S.S., KANG, L.J., LU, R.H. & LEE, S.D. (2000). Effects of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome. J. Gastroenterol. Hepatol., 15, 925-930.
14. LUND-JOHANSEN, P. (1987). Clinical use of calcium antagonists in hypertension: update 1986. J. Cardiovasc. Pharmacol., 10 (Suppl. 10), S29-S35.
15. MCLEOD, J. (1983). Verapamil effective in irritable bowel syndrome? Med. J. Aust., 2, 119.
16. MALYSZ, J., FARRAWAY, L.A., CHRISTEN, M.O. & HUIZINGA, J.D. (1997). Pinaverium acts as L-type calcium channel blocker on smooth muscle of colon. Can. J. Physiol. Pharmacol., 75, 969-975.
17. 1 receptors. Nature, 403, 86-89.
18. NARDUCCI, F., BASSOTTI, G., GABURRI, M., FARRONI, F. & MORELLI, A. (1985). Nifedipine reduces the colonic motor response to eating in patients with the irritable colon syndrome. Am. J. Gastroenterol., 80, 317-319.
19. RUSSELL, R.P. (1988). Side effects of calcium channel blockers. Hypertension, 11, 42-44.
20. SANTICIOLI, P., ZAGORODNYUK, V., RENZETTI, A.R. & MAGGI, C.A. (1999). Antimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon. Naunyn Schmiedebergs Arch. Pharmacol., 359, 420-427.
21. SARIKAYA, S., ASCI, R., AYBEK, Z., YILMAZ, A.F., BUYUKAL-PELLI, R. & YILDIZ, S. (1997). Effects of intracavernous calcium channel blockers in dogs. Int. Urol. Nephrol., 29, 673-680.
22. TALLEY, N.J. (2003). Evaluation of drug treatment in irritable bowel syndrome. Br. J. Clin. Pharmacol., 56, 362-369.